ROYALTY PHARMA PLC- CL A (RPRX) Stock Balance Sheet
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 950.05M | 477.01M | 1.71B | 1.54B | 1.01B | |||
| Marketable Securities | 814.27M | 756.74M | 717.00M | 1.26B | 1.64B | |||
| Receivables | 24.90M | 36.65M | 37.00M | 68.00M | 39.00M | |||
| Other Current Assets | 4.97M | 3.80M | 91.00M | 7.00M | 9.00M | |||
| Total Current Assets | 1.79B | 1.27B | 2.56B | 2.88B | 2.70B | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 16.21B | 15.10B | 14.23B | 14.63B | 13.27B | |||
| Intangibles | N/A | N/A | 0.00 | 6.00M | 29.00M | |||
| Other Non-Current Assets | 42.79M | 6.52M | 30.00M | 4.00M | 29.00M | |||
| Total Non-Current Assets | 16.25B | 15.11B | 14.26B | 14.64B | 13.32B | |||
| TOTAL ASSETS | 18.04B | 16.38B | 16.81B | 17.52B | 16.02B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 996.94M | 0.00 | 998.00M | N/A | 0.00 | |||
| Accrued Expenses | 38.41M | 51.68M | 54.00M | 58.00M | 152.00M | |||
| Accounts Payable | 22.05M | 15.16M | 8.00M | 6.00M | 11.00M | |||
| Other Current Liabilities | 110.35M | 94.53M | 107.00M | 108.00M | 145.00M | |||
| Total Current Liabilities | 1.17B | 161.38M | 1.17B | 171.00M | 308.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.61B | 6.14B | 6.12B | 7.10B | 5.82B | |||
| Other Non-Current Liabilities | 5.58M | 900.00K | 3.00M | N/A | 0.00 | |||
| Total Non-Current Liabilities | 10.00B | 9.69B | 10.02B | 11.57B | 10.89B | |||
| TOTAL LIABILITIES | 11.17B | 9.86B | 11.19B | 11.74B | 11.20B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 2.76B | 2.52B | 1.97B | 2.25B | 1.92B | |||
| Additional Paid In Capital | 4.11B | 4.01B | 3.67B | 3.51B | 2.87B | |||
| Minority Interest | 3.39B | 3.56B | 3.90B | 4.47B | 5.08B | |||
| Common Shares | 108.14K | 108.15K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -2.66M | -2.63M | -3.00M | -3.00M | -2.00M | |||
| Other Shareholders' Equity | -140.00 | -150.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 590.92M | 446.69M | 443.00M | 433.00M | 388.00M | |||
| Tangible Book Value per Share | 11.63 | 14.61 | 12.70 | 13.33 | 12.35 | |||
| Total Shareholders' Equity | 6.87B | 6.53B | 5.63B | 5.78B | 4.82B | |||
| TOTAL LIABILITIES AND EQUITY | 18.04B | 16.38B | 16.81B | 17.52B | 16.02B | |||
| Statistics | ||||||||
| Debt/Equity | 0.96 | 0.94 | 1.09 | 1.23 | 1.21 | |||
| Current Ratio | 1.54 | 7.90 | 2.19 | 16.83 | 8.76 | |||
| Return On Assets (ROA) | 6.35% | 6.93% | 0.25% | 3.54% | 3.09% | |||
| Return On Equity (ROE) | 16.67% | 17.39% | 0.76% | 10.73% | 10.28% | |||
| Return On Invested Capital (ROIC) | 7.23% | 7.27% | 4.66% | 6.52% | 8.35% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 8.07% | 7.87% | 5.52% | 7.77% | 10.04% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 8.07% | 7.87% | 5.52% | 7.78% | 10.06% | |||
All data in USD , ROIC based on taxRate of 0.21